← Latest papers
📄 chemistry

QBD-Based RP-HPLC Method Development and Validation for Estimation of Desidustat in Bulk and Tablet Dosage Form

This study successfully developed and validated a robust, green, Quality by Design (QBD)-guided RP-HPLC method for the precise and stability-indicating quantification of desidustat in bulk and tablet formulations, meeting all ICH Q2(R2) regulatory requirements.

Original authors: Achal Gunjal, Megha Kirve, Shinde Kiran

Published 2026-08-06
📖 4 min read☕ Coffee break read

Original authors: Achal Gunjal, Megha Kirve, Shinde Kiran

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine you are a chef trying to bake the perfect cake, but you don't just want any cake; you need a cake that tastes exactly the same every single time, no matter who bakes it or which oven they use. In the world of medicine, this "cake" is a drug, and the "baking" is the process of making sure the medicine is pure, safe, and effective before it reaches a patient. Scientists use a special tool called High-Performance Liquid Chromatography (HPLC) to taste-test these drugs. Think of HPLC as a high-tech race track where drug molecules run through a long, narrow tunnel. Different molecules run at different speeds, and by timing them, scientists can count exactly how much of the "good stuff" is in the mix. However, sometimes the track conditions—like how hot the oven is or how fast the runners are pushed—can get messy, making the race results unreliable. To fix this, scientists use a strategy called "Quality by Design" (QbD). Instead of guessing and checking one thing at a time (like turning the heat up a little, then the speed a little), QbD is like using a super-smart map to find the perfect combination of settings all at once, ensuring the race is always fair and the results are always trustworthy.

This is exactly what Achal Gunjal and his team at the Vidya Niketan Institute of Pharmacy did for a drug called Desidustat. Desidustat is a new kind of medicine used to help people with chronic kidney disease who suffer from anemia (low red blood cells). It works by tricking the body into thinking it needs more oxygen, which naturally wakes up the body's own factory for making red blood cells. While this drug is a game-changer for patients, the scientists needed a foolproof way to measure it in the lab to ensure every pill contains the right amount. In their study, they didn't just guess the best settings for their HPLC race track; they used a "Quality by Design" approach with a 3² full-factorial design. This is a fancy way of saying they ran a series of nine different experiments, systematically changing the temperature of the oven and the speed of the liquid flow to see how those changes affected the drug's performance. They treated the temperature and flow speed like the knobs on a stereo, looking for the exact setting where the music (the drug signal) is loudest and clearest.

The team discovered that the "sweet spot" for their race track was a temperature of 50°C and a flow speed of 1.0 mL per minute. At these settings, the drug molecules ran through the tunnel perfectly, separating cleanly from any junk or impurities. They also swapped out the usual toxic chemicals for a "green" mixture of ethanol and water, making the process safer for the environment. To prove their method was rock-solid, they put the drug through a gauntlet of stress tests: they boiled it in acid, froze it in base, blasted it with hydrogen peroxide, baked it in a hot oven, and even zapped it with UV light. The drug held up remarkably well, breaking down only slightly under the harshest conditions, and the scientists could still easily spot the original drug among the broken pieces. This proved their method was "stability-indicating," meaning it could tell the difference between the healthy drug and its damaged cousins.

When they tested their new method on actual tablets, it worked like a charm. The tablets contained 99.95% of the medicine they were supposed to have, with almost zero variation between different batches. The method was so precise that if you measured the same sample six times in a row, the results were nearly identical. The authors found that their new approach was far superior to older methods, offering a much clearer picture of the drug's purity and quantity. They didn't just suggest this might work; they measured it, validated it against strict international rules, and showed that it is ready for real-world use in factories and hospitals. By using this smart, systematic approach, they have built a reliable, eco-friendly, and highly accurate tool that ensures every Desidustat pill a patient takes is exactly what it claims to be.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →